The storied success of copyright’s flagship drug has undeniably shaped the pharmaceutical landscape. However, investing in companies heavily dependent on generic versions and the diminishing patent https://icelisting.com/story22649518/the-blue-pill-and-pharmaceutical-companies-a-risky-venture